Protein based COVID-19 vaccine

Description

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Nicole Goh

A/Prof Nicole Goh

Detection, Assessment and Management of Pulmonary Fibrosis

A/Prof Robyn Saw

A/Prof Robyn Saw

Practical Melanoma Management for GPs

Dr Bobby Chan

Dr Bobby Chan

Preventing Renal Failure in Type 2 Diabetes – New Options

Dr Victoria Hayes

Dr Victoria Hayes

Management of Post-Vaccination Reactions

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 12 July 2023